Muscle Relaxants as a Risk Factor for Vis-à-tergo During Penetrating Keratoplasty: A Prospective Interventional Study

Muscle Relaxants as a Risk Factor for Vis-à-tergo During Penetrating Keratoplasty: A Prospective... Adv Ther (2017) 34:2674–2679 DOI 10.1007/s12325-017-0637-1 ORIGINAL RESEARCH Muscle Relaxants as a Risk Factor for Vis-a`-tergo During Penetrating Keratoplasty: A Prospective Interventional Study . . . Miltiadis Fiorentzis Emanuela Morinello Anja Viestenz . . Hanna Zuche Berthold Seitz Arne Viestenz Received: September 25, 2017 / Published online: November 3, 2017 Springer Healthcare Ltd. 2017 nondepolarizing muscle relaxants. VAT was ABSTRACT assessed 15 min after surgery had begun. Results: When mivacurium was used, IOP Introduction: This study aimed to investigate decreased by 2.2 mmHg [standard deviation the influence of three muscle relaxants on (SD) ±2.2 mmHg; p\0.001]. Atracurium intraocular pressure (IOP), ocular pulse ampli- decreased the IOP by an average of 5.8 mmHg tude (OPA), and vis-a`-tergo (VAT) in patients (SD ±1.8 mmHg; p\0.001) and rocuronium undergoing penetrating keratoplasty (PKP) caused an IOP reduction of 7.2 mmHg under general anesthesia. (SD ±2 mmHg; p\0.001). The relative IOP Methods: Ninety-five patients undergoing PKP decrease was 12% with mivacurium, 29% with were included in this prospective single-center atracurium, and 37% with rocuronium interventional study. IOP and OPA were mea- (p\0.001). OPA decreased by 0.6 mmHg with sured with a dynamic contour tonometer before mivacurium (SD ±0.6 mmHg; 26%; p\0.001), and 5 min http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Advances in Therapy Springer Journals

Muscle Relaxants as a Risk Factor for Vis-à-tergo During Penetrating Keratoplasty: A Prospective Interventional Study

Loading next page...
 
/lp/springer_journal/muscle-relaxants-as-a-risk-factor-for-vis-tergo-during-penetrating-PQ60vZ3wOF
Publisher
Springer Healthcare
Copyright
Copyright © 2017 by Springer Healthcare Ltd.
Subject
Medicine & Public Health; Internal Medicine; Oncology; Cardiology; Rheumatology; Endocrinology; Pharmacology/Toxicology
ISSN
0741-238X
eISSN
1865-8652
D.O.I.
10.1007/s12325-017-0637-1
Publisher site
See Article on Publisher Site

Abstract

Adv Ther (2017) 34:2674–2679 DOI 10.1007/s12325-017-0637-1 ORIGINAL RESEARCH Muscle Relaxants as a Risk Factor for Vis-a`-tergo During Penetrating Keratoplasty: A Prospective Interventional Study . . . Miltiadis Fiorentzis Emanuela Morinello Anja Viestenz . . Hanna Zuche Berthold Seitz Arne Viestenz Received: September 25, 2017 / Published online: November 3, 2017 Springer Healthcare Ltd. 2017 nondepolarizing muscle relaxants. VAT was ABSTRACT assessed 15 min after surgery had begun. Results: When mivacurium was used, IOP Introduction: This study aimed to investigate decreased by 2.2 mmHg [standard deviation the influence of three muscle relaxants on (SD) ±2.2 mmHg; p\0.001]. Atracurium intraocular pressure (IOP), ocular pulse ampli- decreased the IOP by an average of 5.8 mmHg tude (OPA), and vis-a`-tergo (VAT) in patients (SD ±1.8 mmHg; p\0.001) and rocuronium undergoing penetrating keratoplasty (PKP) caused an IOP reduction of 7.2 mmHg under general anesthesia. (SD ±2 mmHg; p\0.001). The relative IOP Methods: Ninety-five patients undergoing PKP decrease was 12% with mivacurium, 29% with were included in this prospective single-center atracurium, and 37% with rocuronium interventional study. IOP and OPA were mea- (p\0.001). OPA decreased by 0.6 mmHg with sured with a dynamic contour tonometer before mivacurium (SD ±0.6 mmHg; 26%; p\0.001), and 5 min

Journal

Advances in TherapySpringer Journals

Published: Nov 3, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off